MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. Mediterr J Hematol Infect Dis [Internet]. 2023 Aug. 29 [cited 2026 Apr. 18];15(1):e2023047. Available from: https://www.mjhid.org/mjhid/article/view/5381